JP2015536185A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015536185A5 JP2015536185A5 JP2015539742A JP2015539742A JP2015536185A5 JP 2015536185 A5 JP2015536185 A5 JP 2015536185A5 JP 2015539742 A JP2015539742 A JP 2015539742A JP 2015539742 A JP2015539742 A JP 2015539742A JP 2015536185 A5 JP2015536185 A5 JP 2015536185A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- fully
- magnesium alloy
- absorbent
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000642 polymer Polymers 0.000 claims 39
- 230000002745 absorbent Effects 0.000 claims 23
- 239000002250 absorbent Substances 0.000 claims 23
- 229910000861 Mg alloy Inorganic materials 0.000 claims 17
- 239000003795 chemical substances by application Substances 0.000 claims 14
- 239000011248 coating agent Substances 0.000 claims 14
- 238000000576 coating method Methods 0.000 claims 14
- -1 polytrimethylene carbonate Polymers 0.000 claims 12
- 238000000034 method Methods 0.000 claims 10
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 6
- 229920000954 Polyglycolide Polymers 0.000 claims 6
- 229920001577 copolymer Polymers 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 229920000669 heparin Polymers 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 229920000747 poly(lactic acid) Polymers 0.000 claims 6
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims 6
- 239000000622 polydioxanone Substances 0.000 claims 6
- 229920000728 polyester Polymers 0.000 claims 6
- 239000004633 polyglycolic acid Substances 0.000 claims 6
- 239000004626 polylactic acid Substances 0.000 claims 6
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims 6
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims 6
- 229910052761 rare earth metal Inorganic materials 0.000 claims 6
- 150000002910 rare earth metals Chemical class 0.000 claims 6
- 229960002930 sirolimus Drugs 0.000 claims 6
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 6
- 229940124597 therapeutic agent Drugs 0.000 claims 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 3
- 229940123228 Collagen inhibitor Drugs 0.000 claims 3
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims 3
- 108091034117 Oligonucleotide Proteins 0.000 claims 3
- 229930012538 Paclitaxel Natural products 0.000 claims 3
- 208000031481 Pathologic Constriction Diseases 0.000 claims 3
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims 3
- 229940123237 Taxane Drugs 0.000 claims 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 3
- 230000001028 anti-proliverative effect Effects 0.000 claims 3
- 239000003146 anticoagulant agent Substances 0.000 claims 3
- 239000002246 antineoplastic agent Substances 0.000 claims 3
- 239000003963 antioxidant agent Substances 0.000 claims 3
- 230000003078 antioxidant effect Effects 0.000 claims 3
- 239000000074 antisense oligonucleotide Substances 0.000 claims 3
- 238000012230 antisense oligonucleotides Methods 0.000 claims 3
- 229960004676 antithrombotic agent Drugs 0.000 claims 3
- 229960001716 benzalkonium Drugs 0.000 claims 3
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 claims 3
- 229910052791 calcium Inorganic materials 0.000 claims 3
- 239000011575 calcium Substances 0.000 claims 3
- 229940127089 cytotoxic agent Drugs 0.000 claims 3
- 239000000262 estrogen Substances 0.000 claims 3
- 229940011871 estrogen Drugs 0.000 claims 3
- 229960005167 everolimus Drugs 0.000 claims 3
- 239000003102 growth factor Substances 0.000 claims 3
- 229960002897 heparin Drugs 0.000 claims 3
- 239000002955 immunomodulating agent Substances 0.000 claims 3
- 229940121354 immunomodulator Drugs 0.000 claims 3
- 230000002584 immunomodulator Effects 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 229910052742 iron Inorganic materials 0.000 claims 3
- 238000005304 joining Methods 0.000 claims 3
- 229910052744 lithium Inorganic materials 0.000 claims 3
- 229910052749 magnesium Inorganic materials 0.000 claims 3
- 239000011777 magnesium Substances 0.000 claims 3
- 229910052748 manganese Inorganic materials 0.000 claims 3
- 239000011572 manganese Substances 0.000 claims 3
- 229910052751 metal Inorganic materials 0.000 claims 3
- 239000002184 metal Substances 0.000 claims 3
- 150000002739 metals Chemical class 0.000 claims 3
- 229960001592 paclitaxel Drugs 0.000 claims 3
- 208000037803 restenosis Diseases 0.000 claims 3
- 208000037804 stenosis Diseases 0.000 claims 3
- 229960001967 tacrolimus Drugs 0.000 claims 3
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 3
- 239000011701 zinc Substances 0.000 claims 3
- 229910052725 zinc Inorganic materials 0.000 claims 3
- 239000000463 material Substances 0.000 claims 2
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 238000003698 laser cutting Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261795695P | 2012-10-23 | 2012-10-23 | |
| US61/795,695 | 2012-10-23 | ||
| PCT/US2013/066307 WO2014066465A1 (en) | 2012-10-23 | 2013-10-23 | Fully absorbable intraluminal devices and methods of manufacturing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015536185A JP2015536185A (ja) | 2015-12-21 |
| JP2015536185A5 true JP2015536185A5 (enExample) | 2016-11-10 |
Family
ID=49596443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015539742A Pending JP2015536185A (ja) | 2012-10-23 | 2013-10-23 | 完全吸収性の管腔内装具およびその製造方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150272753A1 (enExample) |
| EP (1) | EP2911710B1 (enExample) |
| JP (1) | JP2015536185A (enExample) |
| KR (1) | KR20150079708A (enExample) |
| CN (1) | CN104870028B (enExample) |
| AU (1) | AU2013334737B2 (enExample) |
| CA (1) | CA2888669A1 (enExample) |
| ES (1) | ES2701066T3 (enExample) |
| WO (1) | WO2014066465A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104225686A (zh) * | 2014-09-30 | 2014-12-24 | 天津大学 | 基于力生长因子和镁合金的复合骨修复材料及其制备方法 |
| CN105055060B (zh) * | 2015-08-04 | 2017-11-14 | 上海交通大学医学院附属上海儿童医学中心 | 一种气管支架及其应用 |
| CN106063949A (zh) * | 2015-09-30 | 2016-11-02 | 圆容生物医药无锡有限公司 | 一种高强度可降解骨内固定复合材料 |
| CN105853022B (zh) * | 2016-06-01 | 2018-02-13 | 上海交通大学医学院附属上海儿童医学中心 | 气管支架及采用该气管支架的组织工程气管及其应用 |
| US10231856B2 (en) * | 2016-10-27 | 2019-03-19 | Cook Medical Technologies Llc | Stent with segments capable of uncoupling during expansion |
| CA3051152A1 (en) | 2017-02-03 | 2018-08-09 | Zorion Medical, Inc. | Wire-formed bio-absorbable implants and methods for assembly |
| GB2566035B (en) * | 2017-08-30 | 2019-11-27 | Medalliance Ltd | Metal alloy and medical device containing same |
| US11998192B2 (en) | 2021-05-10 | 2024-06-04 | Cilag Gmbh International | Adaptive control of surgical stapling instrument based on staple cartridge type |
| US20250090308A1 (en) * | 2022-01-21 | 2025-03-20 | Georgia Tech Research Corporation | Bioresorbable heart valves and methods of making and using same |
| CN114652901B (zh) * | 2022-03-31 | 2023-03-17 | 西南交通大学 | 一种具有防腐和生物活性涂层的镁基材料及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824037A (en) * | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
| US6398803B1 (en) * | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
| US7105018B1 (en) * | 2002-12-30 | 2006-09-12 | Advanced Cardiovascular Systems, Inc. | Drug-eluting stent cover and method of use |
| US8663308B2 (en) * | 2005-09-19 | 2014-03-04 | Cook Medical Technologies Llc | Graft with bioabsorbable support frame |
| CA2663271A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
| US20100256728A1 (en) * | 2009-04-07 | 2010-10-07 | Medtronic Vascular, Inc. | Semi-Permiable Biodegradable Stent Graft and Uses Thereof |
| WO2011119430A1 (en) * | 2010-03-26 | 2011-09-29 | Boston Scientific Scimed, Inc. | Endoprosthesis |
| JP2013529507A (ja) * | 2010-06-21 | 2013-07-22 | ゾリオン メディカル インコーポレイテッド | 生体吸収性インプラント |
| JP5650013B2 (ja) * | 2011-02-28 | 2015-01-07 | 株式会社 京都医療設計 | ステント装置 |
-
2013
- 2013-10-23 US US14/437,374 patent/US20150272753A1/en not_active Abandoned
- 2013-10-23 EP EP13792520.2A patent/EP2911710B1/en not_active Not-in-force
- 2013-10-23 KR KR1020157013058A patent/KR20150079708A/ko not_active Withdrawn
- 2013-10-23 AU AU2013334737A patent/AU2013334737B2/en not_active Ceased
- 2013-10-23 JP JP2015539742A patent/JP2015536185A/ja active Pending
- 2013-10-23 WO PCT/US2013/066307 patent/WO2014066465A1/en not_active Ceased
- 2013-10-23 CA CA2888669A patent/CA2888669A1/en not_active Abandoned
- 2013-10-23 ES ES13792520T patent/ES2701066T3/es active Active
- 2013-10-23 CN CN201380067059.6A patent/CN104870028B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015536185A5 (enExample) | ||
| JP5820370B2 (ja) | 医療用移植片 | |
| EP2911710B1 (en) | Fully absorbable intraluminal devices and methods of manufacturing the same | |
| US9636243B2 (en) | Stent delivery system | |
| US20120143300A1 (en) | Medical implant | |
| WO2004091680A1 (en) | Medical devices having drug eluting properties and methods of manufacture thereof | |
| WO2008048679A3 (en) | Drug-delivery endovascular stent and method of use | |
| US20110118819A1 (en) | Method of manufacturing a polymeric stent with a hybrid support structure | |
| EP3120877A1 (en) | Endoluminal device | |
| US20100244305A1 (en) | Method of manufacturing a polymeric stent having improved toughness | |
| GB2475778A (en) | Implantable medical device comprising a self-expanding tubular structure | |
| WO2009121048A1 (en) | Method of manufacturing a polymeric stent having a circumferential ring configuration | |
| WO2016178251A2 (en) | Drug eluting bioresorbable polymer mesh covered embolic protection implantable device | |
| JP2014233495A (ja) | ステント | |
| WO2011115882A1 (en) | Drug eluting stents and methods of making the same | |
| US20170360552A1 (en) | Expandable Stent with Constrained End | |
| Shidhaye et al. | CORONARY PERFORATIONS AND GENERATION OF STENTS: AN UPDATE AND REVIEW | |
| WO2017154512A1 (ja) | ステントおよびステントデリバリーシステム |